Aetion

Associate Director, Oncology

New York, New York, United States

Not SpecifiedCompensation
Mid-level (3 to 4 years), Senior (5 to 8 years)Experience Level
Full TimeJob Type
UnknownVisa
Healthcare Analytics, Pharmaceutical, Research, Clinical ResearchIndustries

Requirements

Candidates should possess a Master's degree with a minimum of 5 years of experience, or a Doctoral degree with a minimum of 3 years of experience. Strong scientific and strategic leadership skills are required, along with expertise in study designs, analysis approaches, and research methodology, particularly within the oncology field. The role necessitates the ability to provide expert guidance to both internal teams and clients, ensuring alignment with their needs and objectives.

Responsibilities

As an Associate Director, the individual will lead the scientific and analytic services provided to clients, ensuring alignment with their needs and objectives, and overseeing the design and execution of observational research studies focusing on oncology research. They will provide scientific and strategic guidance on study designs, analysis approaches, and research methodology, communicate the scientific impact of evidence generation, and collaborate with cross-functional department leaders to define strategic business goals and drive informed decision-making.

Skills

Study Designs
Analysis Approaches
Research Methodology
Oncology
Scientific Leadership
Strategic Leadership
Communication
Collaboration
Evidence Generation

Aetion

Software solutions for real-world evidence analysis

About Aetion

Aetion develops software solutions that utilize real-world evidence (RWE) to assist life sciences companies, regulators, and purchasers in making informed decisions. Their software analyzes real-world data to provide insights into the effectiveness and safety of medical innovations, from initial hypotheses to long-term monitoring. Aetion's clients include major pharmaceutical companies and healthcare regulators, who benefit from the ability to generate and analyze diverse data sets for clinical insights that were previously hard to obtain. The company differentiates itself by offering a platform that not only manages longitudinal data but also generates synthetic health data using artificial intelligence. Aetion's goal is to maximize the return on investment for its clients by providing rapid insights that facilitate critical decision-making, ultimately expediting patient care and treatment options.

Key Metrics

New York City, New YorkHeadquarters
2012Year Founded
$198MTotal Funding
SERIES_CCompany Stage
AI & Machine Learning, HealthcareIndustries
201-500Employees

Benefits

Medical, dental, & vision insurance
Free membership to OneMedical
FSA
4% 401(k) match
Commuter benefits for parking & transit
Unlimited PTO
Paid parental leave
Wellness stipend
Company activities

Risks

Emerging RWE tech companies pose a threat to Aetion's market share.
Rapid AI advancements may require Aetion to invest heavily in R&D.
Potential EU data privacy law changes could impact Aetion's operations and compliance costs.

Differentiation

Aetion's RWE platform offers real-time collaboration with biopharma and medical device companies.
The company utilizes patented rapid-cycle analytics technology for effective medical treatment insights.
Aetion's software generates synthetic health data using AI for longitudinal data management.

Upsides

Aetion's Barcelona tech hub expansion enhances RWE technology with European talent.
Ken Watson's appointment as CTO is set to drive strategic growth and innovation.
Partnerships like with Intuitive and FDA boost trust in Aetion's regulatory data validation.

Land your dream remote job 3x faster with AI